Together for your growth

You and your team are given access to an immense and diverse community of great minds. The invaluable power of a tight-knit community spread over three different sites to support and accompany you on your success journey.


The Basel Area is considered one of the most important centers for the global health-care industry. The region counts 700 life science companies and a workforce of more than 33,000 well-trained specialists. It prospers thanks to a unique combination of top-grade universities and research organizations, start-ups with ground-breaking ideas, highly innovative SMEs and headquarters of leading global players. The steady economic growth of the area is based on a strong foundation of entrepreneurial thinking, creativity and the combined knowledge of the great minds uniting here for research, development and production.


Companies at Switzerland Innovation Park Basel Area find themselves in the midst of this thriving ecosystem and residents are given every opportunity to profit from the Park’s excellent network in the academic and corporate world. In addition, each of the three sites is located in highly beneficial surroundings. The industrial area that is home to the Allschwil site has become an important life sciences hub rich with opportunities and synergies. The Park’s pending move to the brand-new GRID premises just across the street will only amplify these already favorable conditions create and open up more doors for residents. The Basel site is part of the Technologiepark Basel, one of the premier addresses for tech start-ups in Basel. It is located in the rapidly growing Stücki Park in the dynamic northern part of the city. The site in Delémont (Canton of Jura), finally, was specifically designed to foster collaboration between traditional local companies, academic groups and progressive start-ups with a focus on medtech and robotics.


The most important network, however, may very well be found within Switzerland Innovation Park Basel Area. Founders will meet like-minded scientists who have faced some of the same challenges and gone through the same stages of entrepreneurship. The entire concept featuring shared and communal spaces is geared to promote fruitful exchange and cooperation on all levels among residents.

Current residents

The following research groups and companies are part of the Switzerland Innovation Park Basel Area community:

Ad Mirabiles AG: Patient specific implants for any type of indication, focusing in particular on CMF applications and PEEK implants.

aiNET GmbH:  leverages artificial intelligence and large-scale networks for data analytics. aiNET serves pharmaceutical industries and biotechs discover biologics from next-generation sequencing big data.

Alibion AG:  a biotech company focused on the early stage development of the first personalized medicine against Rheumatoid Arthritis.

Amzell: acquires early stage drug or combination product (drug-device) candidates and repurposed drugs and develop them through proof of concept to registration for sale to commercial healthcare companies.

Aurteen GmbH: develops software that uses machine learning to provide low-cost non-invasive screening solutions to detect blinding disorders and brings accessible high-quality-diagnostic care to the general population.

Blackway Biosciences AG: BlackWay Biosciences AG provides preclinical drug discovery and development services across a spectrum of indications in the space of cardiometabolic and rare diseases, and across multiple modalities including small molecules, biologics and oligonucleotide therapeutics.

Captor Therapeutics: Polish biotech company developing drug candidates for the treatment of oncology and chronic inflammation.

Catalyze: Catalyze helps researchers and companies secure financing for ambitious R&D projects, from early stage pre-clinical research up to clinical stage development.

Coretag: Coretag discovered and now develops a platform technology that specifically targets to necrotic cells. The Radioligand diagnostics visualizes all types of necrosis in living tissue within 24-hours of application.

Cimeio Therapeutics AG: CIMEIO develops game changing immunotherapies for leukemic tumors, non-malignant blood disorders, auto-immune diseases and tolerance for organ transplantation.

Department of Biomedical Engineering (DBE), University of Basel: More than twenty research groups with the subsequent focal areas: Biomechanics and biomaterials, computational modelling, imaging and image analysis, laser and robotics, regenerative medicine.

Di Meliora AG: New dental implant designs that aim to solve challenges like marginal bone loss, implant cleaning, bone augmentation.

GeneLook AG: In the genetic era GeneLook lets you manage your DNA from the palm of your hand. We offer you value in real time ranging from understanding your susceptibility to disease risks, or what foods are good for you, to even understanding your personality traits based on your genetics.

GPRS – Gombert Pharma Research Solutions: Offers consultancy and services for pharmaceutical research. Our aim is to support our clients in all aspects of identifying new targets, drug candidates and therapies through drug discovery and early clinical development phases.

Hamilton Bonaduz AG: Within the Robotics business unit, Hamilton develops and manufactures pipetting robots to automate liquid handling processes. As part of Switzerland Innovation Park Basel Area, we are currently developing applications on various robotic platforms in a laboratory, where the applications can also be biologically tested.

HealthHack Lab: We are a non profit lab for patients, caregivers and innovators to co-create solutions that address everyday health challenges. We bring people, training, knowledge and equipment together to help others to improve their lives step by step.

KetoSwiss AG: A University of Basel spinoff- brings an efficient and long-neglected fuel for the brain (ketone bodies) back into the modern world, to combat neurological diseases, such as migraine.

Pattern Biosciences: Next generation programmable therapies powered by Synthetic Biology.

Peter Kelly Pharma: Drug-discovery, specializing in diseases of the nervous system, such as Alzheimer’s Disease.

Q-Linked AG: We consult, support and accompany enterprises during an envisaged ISO certification and provide high quality assistance during staffing bottleneck. We strive for intelligible and useful solutions and are able to provide, thanks to our contemporary understanding of Quality Management, a practice-oriented management and early-warning system.

QCPT Services GmbH: provides services in life science and information technology industry. The four letters QCPT stand for our service portfolio: Quality & Compliance services, Consulting services, Project Management and Training. Our Quality & Compliance services focus on Computerized System Validation, GxP assessments, Data Integrity, eCompliance Quality Assurance, GMP Quality Control Frameworks and internal audits related to these topics.

Soladis GmbH: Soladis is a data expert. Its unique know-how in statistics, biostatistics, bioinformatics, clinical trials, data science, IoT and digitalization makes Soladis the perfect partner for your data-related projects.

SunRegen Healthcare AG: SunRegen is a biopharmaceutical company focusing on developing innovative treatments for patients with neurodegenerative diseases.

Spheroidals: Spin-off from the University Hospital Basel. This company devotes itself to developing novel nanotechnologies in medical application, mainly focusing on non-invasive imaging of atherosclerosis and targeted anti-atherosclerosis therapy.

Synendos Therapeutics: Biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.


Alumni Companies

Congratulations to these alumni companies of Switzerland Innovation Park Basel Area:


AOT: Is the first company worldwide to develop a surgical robotic platform, named CARLO, to cut bone with a «cold» photoablation laser, leaving bone structures intact and vital, and thus pioneering the new field of «Laser-Osteotomy».

Blackbird Project GmbH: Blackbird Projects provides advisory services to technology companies in the following fields: Image Sensors, 3-D imaging, Semiconductor Lasers, and Health Monitoring / Diagnostics.

Mininavident: The DENACAM System by Mininavident is a highly innovative 3D realtime navigation system for the

precise implantation of dental implants.

Polyneuron: Development of a promising new drug class to treat autoimmune disorders

Predemtec: Research, development and manufacturing of innovative diagnostic tests for the diagnosis of risk factors of dementias

Skyhawk Therapeutics: Drug discovery company with a novel platform to develop small molecules targeting RNA

The Farm&Co: The Farm & Co is a start-up company that creates, develops and design chatbots to improve healthcare management.

Versameb AG: Research and development in the field of regenerative medicine, looking to design novel technologies



The following scientific partners are actively involved in Switzerland Innovation Park Basel Area and ready to engage with its residents:



Department of Biosystems Science and Engineering (D-BSSE) of ETH Zurich

Swiss Institute for Computer Assisted Surgery

Swiss Tropical and Public Health Institute

University Hospital Basel

University of Applied Sciences and Arts Northwestern Switzerland

University of Basel